Log In
Print
BCIQ
Print
Print this Print this
 

Zuplenz, ondansetron

  Manage Alerts
Collapse Summary General Information
Company MonoSol Rx LLC
DescriptionSelective serotonin (5-HT3) receptor antagonist
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationEmesis
Indication DetailsPrevent and treat nausea and vomiting
Regulatory Designation

Partner

Galena Biopharma Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today